Pharma & Biotech
A Closer Look at Sellas Life Sciences’ Promising Cancer Pipeline
Sellas Life Sciences is generating significant attention with two advanced cancer therapies showing compelling clinical results. The biotechnology firm's innovative...
Baxter Shares Show Signs of Recovery Amidst Ongoing Challenges
After an extended period of decline, Baxter International Inc. shares have demonstrated a surprising uptick, posting significant gains in the...
Pliant Therapeutics Shares Plummet Following Clinical Trial Setback
Pliant Therapeutics Inc. is facing a severe market downturn as its share price experiences significant erosion. This steep decline comes...
Xtant Medical’s Strategic Shift: A Bold Move or Misstep?
Xtant Medical, a specialist in the medical technology sector, is navigating a complex strategic pivot. The company recently announced record-breaking...
Aligos Therapeutics Shares Surge Ahead of Key Scientific Forums
Shares of Aligos Therapeutics Inc experienced a significant rally on Friday, climbing 6.15% to close at $11.40 after reaching an...
A New Chapter Begins as Walgreens Boots Alliance Goes Private in Landmark Deal
The acquisition of Walgreens Boots Alliance by Sycamore Partners has been finalized, marking a significant turning point for the major...
A Watershed Year Approaches for Cytosorbents as FDA Decision Looms
The investment thesis for medical technology firm Cytosorbents hinges on a single, pending regulatory milestone. With its innovative DrugSorb-ATR blood...
ClearPoint Neuro’s Expanded FDA Clearance: A Potential Catalyst for Growth
Medical technology company ClearPoint Neuro has secured a significant regulatory expansion for its Neuro-Laser Therapy System. The latest FDA clearance...
BioNTech’s Oncology Ambitions Advance with Promising Breast Cancer Trial Data
BioNTech SE has achieved a significant milestone in its oncology pipeline, with a novel breast cancer therapy demonstrating superior results...
Cardinal Health Bets Big on Urology with $1.9 Billion Acquisition
In a major strategic move, healthcare distributor Cardinal Health is making a nearly $2 billion wager to accelerate its growth...
Don't Miss It
Popular News
-
SunHydrogen Set for European Debut with Groundbreaking Technology
-
Exploring the Rise of AI in Empowering Business and Personal Growth: Trends and Innovations
-
Trade Desk Shares Face Mounting Pressure as Tariff Warnings Materialize
-
Kraft Heinz Stock: A Contradiction in Market Sentiment
-
Synopsys Shares Plummet Amid Fraud Allegations and Disappointing Earnings
